{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "53e3d869-e48d-4a59-b14d-493f7d5b0d68", "code": "50-37-3", "type": "PRIMARY", "url": "https://commonchemistry.cas.org/detail?cas_rn=50-37-3", "code_system": "CAS", "references": [ "4b016d08-0889-474f-ad8e-51877b284c64", "681e3993-f6e8-4834-8ef1-bd6e12a4960e" ] }, { "uuid": "ef2f5246-e3a9-45fb-bb39-ebde8fd746cc", "code": "D008238", "type": "PRIMARY", "url": "http://www.ncbi.nlm.nih.gov/mesh/68008238", "code_system": "MESH", "references": [ "4b016d08-0889-474f-ad8e-51877b284c64" ] }, { "uuid": "88399dd0-513c-4a44-b572-59ba96e6f451", "code": "LYSERGIC ACID DIETHYLAMIDE", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/Lysergic_acid_diethylamide", "code_system": "WIKIPEDIA", "references": [ "4b016d08-0889-474f-ad8e-51877b284c64" ] }, { "uuid": "a5f54a08-93ee-4df2-943c-36f55bf51320", "code": "SUB08628MIG", "type": "PRIMARY", "code_system": "EVMPD", "references": [ "4b016d08-0889-474f-ad8e-51877b284c64" ] }, { "uuid": "73c32dba-9c23-4293-a7dc-604ee47e70f7", "code": "729", "type": "PRIMARY", "url": "https://extranet.who.int/soinn/mod/page/view.php?id=137&inn_n=729", "code_system": "INN", "references": [ "4b016d08-0889-474f-ad8e-51877b284c64" ] }, { "uuid": "efd2f60c-0604-463c-a07d-a1f3f61fc62c", "code": "7315", "comments": "PART 1308 -- SCHEDULES OF CONTROLLED SUBSTANCES|Sec. 1308.11 Schedule I.|Hallucinogenic substances", "type": "PRIMARY", "url": "http://www.ecfr.gov/cgi-bin/text-idx?rgn=div5&node=21:9.0.1.1.9#se21.9.1308_111", "code_system": "DEA NO.", "references": [ "4b016d08-0889-474f-ad8e-51877b284c64" ] }, { "uuid": "88879bbb-c99a-4676-a06e-cae869d87d3e", "code": "PL 002", "type": "PRIMARY", "code_system": "INCB IDS CODE", "references": [ "4b016d08-0889-474f-ad8e-51877b284c64" ] }, { "uuid": "b11031fc-d662-4685-b2d2-9bce20ff4874", "code": "C76104", "type": "PRIMARY", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C76104", "code_system": "NCI_THESAURUS", "references": [ "4b016d08-0889-474f-ad8e-51877b284c64" ] }, { "uuid": "7959d57a-d6af-40be-890e-372d44f26149", "code": "m6965", "comments": "Merck Index", "type": "PRIMARY", "url": "https://merckindex.rsc.org/monographs/m6965?q=authorize", "code_system": "MERCK INDEX", "references": [ "4b016d08-0889-474f-ad8e-51877b284c64" ] }, { "uuid": "4973f84e-27ff-48fa-9d37-e1044393138d", "code": "21 CFR 862.3580", "comments": "PART 862 -- CLINICAL CHEMISTRY AND CLINICAL TOXICOLOGY DEVICES|Subpart D--Clinical Toxicology Test Systems|Sec. 862.3580 Lysergic acid diethylamide (LSD) test system.", "type": "PRIMARY", "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=862.3580", "code_system": "CFR", "references": [ "4b016d08-0889-474f-ad8e-51877b284c64" ] }, { "uuid": "a1ddc73c-8c91-4707-b7db-0e0ee943de35", "code": "CHEMBL263881", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881", "code_system": "ChEMBL", "references": [ "4b016d08-0889-474f-ad8e-51877b284c64" ] }, { "uuid": "a553392a-a52d-41ea-99b8-123e150be084", "code": "200-033-2", "type": "PRIMARY", "url": "https://echa.europa.eu/substance-information/-/substanceinfo/100.000.031", "code_system": "ECHA (EC/EINECS)", "references": [ "4b016d08-0889-474f-ad8e-51877b284c64" ] }, { "uuid": "dee210dc-5200-46a3-ab61-d4db1d9b4480", "code": "5761", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5761", "code_system": "PUBCHEM", "references": [ "4b016d08-0889-474f-ad8e-51877b284c64" ] }, { "uuid": "28288427-2dc0-5e0b-12ec-71d14312027f", "code": "3920", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3920", "code_system": "HSDB", "references": [ "bc4ae17d-5304-c667-760f-b86786883734" ] }, { "uuid": "92367084-010d-9d1e-bda5-83c7124c8381", "code": "DTXSID1023231", "type": "PRIMARY", "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID1023231", "code_system": "EPA CompTox", "references": [ "ec19f587-04cd-0e11-999c-fab3e689ba5a" ] }, { "uuid": "0f0c1414-1c06-1f49-e388-3bb1d6ba3c1a", "code": "C66885", "comments": "Pharmacologic Substance[C1909]|Agent Affecting Nervous System[C78272]|Serotonin Antagonist", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C66885", "code_system": "NCI_THESAURUS", "references": [ "ea13361d-d8b8-7f8f-7d3b-197998ac85b6" ] }, { "uuid": "8328a39a-d42d-809a-f050-43aa385f2aac", "code": "C47794", "comments": "Pharmacologic Substance[C1909]|Agent Affecting Nervous System[C78272]|Serotonin Agonist", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47794", "code_system": "NCI_THESAURUS", "references": [ "ea13361d-d8b8-7f8f-7d3b-197998ac85b6" ] }, { "uuid": "d8cd7e07-770c-45a2-946c-937eab7b5f17", "code": "8NA5SWF92O", "type": "PRIMARY", "code_system": "FDA UNII", "references": [ "b502f3f9-4b7c-48ff-b6cc-79d6bce4b0de" ] }, { "uuid": "1aeb6327-5180-8662-4b2d-0a05806b0179", "code": "1621", "type": "PRIMARY", "url": "https://drugcentral.org/drugcard/1621", "code_system": "DRUG CENTRAL", "references": [ "ea13361d-d8b8-7f8f-7d3b-197998ac85b6" ] }, { "uuid": "b0fe1497-aa42-771a-3944-06ceb0380a6e", "code": "DB04829", "type": "PRIMARY", "url": "https://go.drugbank.com/drugs/DB04829", "code_system": "DRUG BANK", "references": [ "ea13361d-d8b8-7f8f-7d3b-197998ac85b6" ] }, { "uuid": "7b3a8af4-f497-8fcb-cbcb-a2555d273859", "code": "6605", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:6605", "code_system": "CHEBI", "references": [ "ea13361d-d8b8-7f8f-7d3b-197998ac85b6" ] }, { "uuid": "fed6f80f-62a1-9056-c0f0-84403c291151", "code": "100000081735", "type": "PRIMARY", "code_system": "SMS_ID", "references": [ "c9d1579d-a880-cca1-f5f3-6fa78e9c0ee6" ] }, { "uuid": "e8788dff-78a9-5236-2865-ddba37f21f3c", "code": "TiHKAL", "comments": "Wikipedia|TiHKAL|Tryptamines", "type": "CONCEPT", "url": "https://en.wikipedia.org/wiki/TiHKAL", "code_system": "WIKIPEDIA", "references": [ "ea13361d-d8b8-7f8f-7d3b-197998ac85b6" ] } ], "relationships": [ { "uuid": "563901fe-d58c-4ba9-aa03-4d7ee0b881c2", "amount": { "uuid": "d371a0f3-d8d5-4a65-aba7-c6e95bfe7c71" }, "type": "ACTIVE MOIETY", "related_substance": { "uuid": "4eb03d57-3c52-4945-ac9a-f35d4a5b9c82", "refuuid": "47838978-2214-4228-a38b-9ed5b1b283a3", "name": "LYSERGIDE", "unii": "8NA5SWF92O", "linking_id": "8NA5SWF92O", "ref_pname": "LYSERGIDE", "substance_class": "reference" } }, { "uuid": "f86507e5-7b01-4fea-9f4f-0df88123b82b", "amount": { "uuid": "5bf6147f-b35d-4b74-a55e-29f305f48b1c" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "189d1c10-fa64-4f40-ab9f-3693310c14e0", "refuuid": "17cdadd2-cecb-4dbb-bebf-76cf02621a1f", "name": "LYSERGIDE MALEATE", "unii": "79LNZ35K7M", "linking_id": "79LNZ35K7M", "ref_pname": "LYSERGIDE MALEATE", "substance_class": "reference" } }, { "uuid": "799ca41d-2cb1-486c-9b18-34e301227a53", "amount": { "uuid": "4703b6f5-00ee-4041-b060-b042e8cae152" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "a161b257-11d3-434a-ac5a-8dd478501790", "refuuid": "55b68f2e-d57e-44bd-90d4-155b93d4b63f", "name": "LYSERGIDE TARTRATE", "unii": "KXF3755R6D", "linking_id": "KXF3755R6D", "ref_pname": "LYSERGIDE TARTRATE", "substance_class": "reference" } }, { "uuid": "9e777c56-d8c6-4bec-a1a1-36fe2b3dd35d", "amount": { "uuid": "3787d6ba-b699-448d-b808-9d16e291809c" }, "qualification": "URINE", "type": "METABOLITE->PARENT", "references": [ "b45491c0-bdbb-4424-b7ff-237e9904d014" ], "related_substance": { "uuid": "e3326bb1-c72f-4528-8c14-44f19d77847d", "refuuid": "4a938906-8d4e-4e4c-81ee-1b496b0afbe3", "name": "2-OXO-3-HYDROXY-LYSERGIDE", "unii": "KU55DR6345", "linking_id": "KU55DR6345", "ref_pname": "2-OXO-3-HYDROXY-LYSERGIDE", "substance_class": "reference" } }, { "uuid": "96f083b0-02e7-43c8-8aed-0e3ffabaf257", "amount": { "uuid": "a1e8c615-668c-4e94-81fb-ce8f172ef85f", "average": 340, "high": 375, "low": 305, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "OFF TARGET->LIGAND", "interaction_type": "BINDING", "references": [ "b502f3f9-4b7c-48ff-b6cc-79d6bce4b0de" ], "related_substance": { "uuid": "6cc5eb71-6cf7-4906-850d-cfe434c6dac3", "refuuid": "7d15e9e6-b6eb-4b58-9bc0-a2bdb303b579", "name": "D(1B) DOPAMINE RECEPTOR", "unii": "EI9KB27FI6", "linking_id": "EI9KB27FI6", "ref_pname": "D(1B) DOPAMINE RECEPTOR", "substance_class": "reference" } }, { "uuid": "43857ad9-7ac1-4210-a850-a60fe81b6111", "amount": { "uuid": "a1c75f7a-8fd4-4e3c-891b-350a62d359b3", "average": 56, "high": 68, "low": 44, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "OFF TARGET->LIGAND", "interaction_type": "BINDING", "references": [ "b502f3f9-4b7c-48ff-b6cc-79d6bce4b0de" ], "related_substance": { "uuid": "e0d9f4f6-d589-446c-921f-b26b0441595d", "refuuid": "ea992769-afc0-4ea1-a836-2b3c94ce32cd", "name": "D(4) DOPAMINE RECEPTOR", "unii": "RI471QC62V", "linking_id": "RI471QC62V", "ref_pname": "D(4) DOPAMINE RECEPTOR", "substance_class": "reference" } }, { "uuid": "e33001a8-c319-48bb-b37b-864b806cb423", "amount": { "uuid": "b5f56878-a45f-48fc-a4ab-d361da5c3c7e" }, "type": "METABOLITE->PARENT", "references": [ "92b30819-12d9-4ad2-884f-dc939b389926" ], "related_substance": { "uuid": "e9fb9a57-f88a-457b-8f7f-e08f36afff2d", "refuuid": "1dd03782-f523-407f-8f70-2c34318183b5", "name": "2,3-DIHYDROXY LYSERGIC ACID DIETHYLAMIDE", "unii": "3W5X1R8NAY", "linking_id": "3W5X1R8NAY", "ref_pname": "2,3-DIHYDROXY LYSERGIC ACID DIETHYLAMIDE" } }, { "uuid": "bc71c39d-c54f-4afe-91e0-49bf936864a4", "amount": { "uuid": "09d05271-1b9c-4574-a302-778f9c99f224" }, "type": "SALT/SOLVATE->PARENT", "references": [ "cdad751e-295f-427b-b801-f3145c766c3b" ], "related_substance": { "uuid": "07674ea4-f1e0-47d0-8ae5-4fb437098fc7", "refuuid": "2c21ea2f-07a3-4358-82b6-cb119737a5c9", "name": "LYSERGIC ACID DIETHYLAMIDE HYDROBROMIDE", "unii": "37M5TWK4Q4", "linking_id": "37M5TWK4Q4", "ref_pname": "LYSERGIC ACID DIETHYLAMIDE HYDROBROMIDE" } }, { "uuid": "eb683cae-c3a6-4119-b528-8baa133fd5ba", "amount": { "uuid": "455f8f56-be37-4251-a343-ae2a23db75d8", "average": 3.5, "high": 4.12, "low": 2.88, "units": "NANOMOLAR" }, "comments": "[125I]DOI was the radioligand.", "qualification": "Ki", "type": "TARGET->AGONIST", "references": [ "b502f3f9-4b7c-48ff-b6cc-79d6bce4b0de" ], "related_substance": { "uuid": "63df3a35-0292-4109-a771-b408bf4f9d66", "refuuid": "d78d31c8-4aa9-4058-b1bc-4b11d2e862e3", "name": "5-HYDROXYTRYPTAMINE RECEPTOR 2A", "unii": "NQI5D806LC", "linking_id": "NQI5D806LC", "ref_pname": "5-HYDROXYTRYPTAMINE RECEPTOR 2A", "substance_class": "reference" } }, { "uuid": "7bc28a07-c04e-4f13-9620-467af023c6bf", "amount": { "uuid": "e3b8bdc9-8cdd-4337-9364-7797559cc12d", "average": 5.5, "high": 5.81, "low": 5.19, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "TARGET->AGONIST", "references": [ "b502f3f9-4b7c-48ff-b6cc-79d6bce4b0de" ], "related_substance": { "uuid": "9d691e98-e930-432e-8bc2-bd2c932c59c7", "refuuid": "c6fd7267-1e34-44af-a91e-31fc68e4c295", "name": "5-HYDROXYTRYPTAMINE RECEPTOR 2C", "unii": "W4BO00H6K6", "linking_id": "W4BO00H6K6", "ref_pname": "5-HYDROXYTRYPTAMINE RECEPTOR 2C", "substance_class": "reference" } }, { "uuid": "5c4f92f8-5ef6-4f1e-b76a-4658dff57ad9", "amount": { "uuid": "7ddcfe97-039d-43c2-a924-e78d0480c03d", "average": 1.1, "high": 1.11, "low": 1.09, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "TARGET->AGONIST", "references": [ "b502f3f9-4b7c-48ff-b6cc-79d6bce4b0de" ], "related_substance": { "uuid": "ab684543-2fbf-4a03-8478-91d6324fd665", "refuuid": "9bfef87f-df60-4cc3-a78f-4a9ab1339e24", "name": "5-HYDROXYTRYPTAMINE RECEPTOR 1A", "unii": "UKK18ES9TF", "linking_id": "UKK18ES9TF", "ref_pname": "5-HYDROXYTRYPTAMINE RECEPTOR 1A", "substance_class": "reference" } }, { "uuid": "76751934-e6e2-415b-ab27-38a95b93e773", "amount": { "uuid": "77a87061-a4f4-4c6c-932a-ab00554d860a", "average": 14.7, "high": 18.9, "low": 10.5, "units": "NANOMOLAR" }, "comments": "[3H]ketanserin radioligand", "qualification": "Ki", "type": "TARGET->AGONIST", "references": [ "7bf14301-5db2-49ac-aac2-57bad9ed5093" ], "related_substance": { "uuid": "ac45765b-3132-4e44-bffe-3b5d46524f34", "refuuid": "d78d31c8-4aa9-4058-b1bc-4b11d2e862e3", "name": "5-HYDROXYTRYPTAMINE RECEPTOR 2A", "unii": "NQI5D806LC", "linking_id": "NQI5D806LC", "ref_pname": "5-HYDROXYTRYPTAMINE RECEPTOR 2A", "substance_class": "reference" } }, { "uuid": "73d484fb-0516-434a-a79a-41434c71019a", "amount": { "uuid": "91256245-6908-47d9-aebd-a6f75630bbbe" }, "type": "SALT/SOLVATE->PARENT", "references": [ "c6826751-2276-4204-a386-a78b2a1055c5" ], "related_substance": { "uuid": "ce12e381-5e6b-4558-b4f1-7ca3a1f07104", "refuuid": "d8e3690b-9b03-4007-91d9-cefdb3a8a2fe", "name": "LYSERGIDE D-TARTRATE", "unii": "7WNP51KA7M", "linking_id": "7WNP51KA7M", "ref_pname": "LYSERGIDE D-TARTRATE" } }, { "uuid": "c8baa6cf-0012-4449-b284-b25941668612", "amount": { "uuid": "2b2730ed-200a-4aa6-9fcd-e67b6fcb6cc1" }, "comments": "High levels of LSD were detected in the plasma of rats after subcutaneous administration of ALD-52 and 1P-LSD, demonstrating these compounds are rapidly and efficiently deacylated in vivo.", "type": "PRODRUG->METABOLITE ACTIVE", "references": [ "39860e9a-54df-47ef-8295-f3cc15b82d01" ], "related_substance": { "uuid": "4f48e861-6d03-4836-95af-cfa3a0a9b500", "refuuid": "31f3391a-1341-496c-8c04-1f343e3833eb", "name": "ALD-52", "unii": "R224WJZ8M7", "linking_id": "R224WJZ8M7", "ref_pname": "ALD-52" } }, { "uuid": "36825f1b-00c1-41f0-a902-ed07521a023e", "amount": { "uuid": "1da61c62-9ee5-4910-bc23-c93737fee540" }, "type": "PRODRUG->METABOLITE ACTIVE", "related_substance": { "uuid": "5655b65e-9e14-4dc6-86bb-202ca6d44bba", "refuuid": "ced1f026-ad94-4600-a503-bd31d6c25741", "name": "1V-LSD", "unii": "V9TJ3HT283", "linking_id": "V9TJ3HT283", "ref_pname": "1V-LSD" } }, { "uuid": "041441f9-8d97-460a-beb5-b3920f66f77f", "amount": { "uuid": "b18385a7-9240-41f5-a5a4-dc0c8e0dea80" }, "comments": "A recent intoxication case involving 1P-LSD indicated formation of LSD in vivo with no detection of the parent molecule.", "type": "PRODRUG->METABOLITE ACTIVE", "references": [ "28b0f01c-0ac0-47de-9969-43dc6bcac1db" ], "related_substance": { "uuid": "560b8b71-910d-4e29-8aff-76e1ddbaf91a", "refuuid": "1637551e-2710-4ac1-b4ee-7120648efa5a", "name": "1-PROPIONYL-LYSERGIC ACID DIETHYLAMIDE", "unii": "23R2G2G79C", "linking_id": "23R2G2G79C", "ref_pname": "1-PROPIONYL-LYSERGIC ACID DIETHYLAMIDE" } }, { "uuid": "4310b935-6227-4404-9fc8-eb81ad8663fe", "amount": { "uuid": "abcd1ab6-368b-41f0-ba23-59f03a6b37c1" }, "type": "DERIVATIVE->PARENT", "references": [ "de5941ca-20b4-4192-a232-12882cc65582" ], "related_substance": { "uuid": "566e1f0d-2a50-414c-8e2a-2b3f32e1dcb7", "refuuid": "4fce5cbe-f83a-4fa9-b1c8-b5cf701e6484", "name": "BU-LAD", "unii": "4Z2TQQ6ZTC", "linking_id": "4Z2TQQ6ZTC", "ref_pname": "BU-LAD" } }, { "uuid": "23c73be0-fcc6-4c6e-b44d-0606c561f627", "amount": { "uuid": "9875f195-c87b-479e-9f0a-8ab824e331f2" }, "type": "PRODRUG->METABOLITE ACTIVE", "references": [ "886c1d71-9665-44a9-82d8-71dc1dab2c48", "5f567722-67d3-447c-ab84-b44b2d47853e" ], "related_substance": { "uuid": "abd948e3-95fa-4d5f-8c5c-bbce51cb407f", "refuuid": "821f6ac8-1dd6-4c36-9689-c2b2cc178e52", "name": "1B-LSD", "unii": "Y6JQX3L6LP", "linking_id": "Y6JQX3L6LP", "ref_pname": "1B-LSD" } }, { "uuid": "9ef98852-2ce2-433e-a102-52d0f5e4a0a9", "amount": { "uuid": "9595c1c9-8212-47ed-9eff-7b9049fe854c" }, "type": "PRECURSOR->PARENT", "related_substance": { "uuid": "3aaf70d6-a50e-4034-ab04-dc1ac2dab122", "refuuid": "4322340c-5f88-4797-b2e4-bc835e495535", "name": "Diethylamine", "unii": "B035PIS86W", "linking_id": "B035PIS86W", "ref_pname": "Diethylamine", "substance_class": "reference" } }, { "uuid": "3e139091-26a6-4cec-b7f1-20a68aeba5f0", "amount": { "uuid": "0631da1a-4bf7-4a7b-b5fa-937225556f54" }, "type": "PRECURSOR->PARENT", "references": [ "549fde70-9d06-468e-8a04-5b9afa511ca5" ], "related_substance": { "uuid": "4df09a62-7bd1-4503-a01b-cfa4afdd79e9", "refuuid": "1796b8fe-b1cd-42bf-a178-8898ddd5197e", "name": "ERGONOVINE", "unii": "WH41D8433D", "linking_id": "WH41D8433D", "ref_pname": "ERGONOVINE", "substance_class": "reference" } }, { "uuid": "2f33c97c-20fc-49ab-8347-a491b262d488", "amount": { "uuid": "c9469d84-6d3d-477f-be96-f4ca9761a8d9", "average": 6.6, "high": 8.1, "low": 5.1, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "TARGET->AGONIST", "references": [ "b502f3f9-4b7c-48ff-b6cc-79d6bce4b0de" ], "related_substance": { "uuid": "0d82951b-f0d9-4848-8f7b-f73ebd6637b0", "refuuid": "6553e5f0-2569-4628-83e7-d485f6f564d7", "name": "5-HYDROXYTRYPTAMINE RECEPTOR 7", "unii": "1AG1A6ENX6", "linking_id": "1AG1A6ENX6", "ref_pname": "5-HYDROXYTRYPTAMINE RECEPTOR 7", "substance_class": "reference" } }, { "uuid": "c79e352d-a500-49d5-804a-bcfbb2ed9b29", "amount": { "uuid": "54da5fff-aadf-4857-9146-5609d2ff5bb1", "average": 6.9, "high": 7.44, "low": 6.36, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "TARGET->AGONIST", "references": [ "b502f3f9-4b7c-48ff-b6cc-79d6bce4b0de" ], "related_substance": { "uuid": "bc7367e3-ef77-4251-bb0b-e8553e3bb4ef", "refuuid": "792063d5-3ef4-48c1-88d2-24b2ed4b6760", "name": "5-HYDROXYTRYPTAMINE RECEPTOR 6", "unii": "Z3LSI83ND8", "linking_id": "Z3LSI83ND8", "ref_pname": "5-HYDROXYTRYPTAMINE RECEPTOR 6", "substance_class": "reference" } }, { "uuid": "79aaed63-cdb0-4ab0-a640-a0e9a86a96ea", "amount": { "uuid": "4bc3970d-7f09-4957-8d79-07fad84660fb", "average": 9, "high": 10.8, "low": 7.2, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "TARGET->AGONIST", "references": [ "b502f3f9-4b7c-48ff-b6cc-79d6bce4b0de" ], "related_substance": { "uuid": "63f11dda-7d92-4936-8117-454b77e16166", "refuuid": "62d81d85-0e19-4628-8b45-e312f9a7b6a1", "name": "5-HYDROXYTRYPTAMINE RECEPTOR 5A", "unii": "JFQ71N5YWI", "linking_id": "JFQ71N5YWI", "ref_pname": "5-HYDROXYTRYPTAMINE RECEPTOR 5A", "substance_class": "reference" } }, { "uuid": "3ab40a90-6925-4b8e-bdca-46a7ac275a27", "amount": { "uuid": "825f4224-2deb-417e-a3f1-a07f64ee193e", "average": 3.9, "high": 4.66, "low": 3.14, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "TARGET->AGONIST", "references": [ "b502f3f9-4b7c-48ff-b6cc-79d6bce4b0de" ], "related_substance": { "uuid": "07da6cea-3edc-4c2b-867d-16a0c933515b", "refuuid": "9753abf8-4dac-4cb5-b55b-d9fec4748d6d", "name": "5-HYDROXYTRYPTAMINE RECEPTOR 1D", "unii": "ZI18M2JAY5", "linking_id": "ZI18M2JAY5", "ref_pname": "5-HYDROXYTRYPTAMINE RECEPTOR 1D", "substance_class": "reference" } }, { "uuid": "eb747a68-6816-4ddd-837b-236f3ddb2e81", "amount": { "uuid": "c2bd7831-9b1e-40be-8ea0-6db65a6669f8", "average": 93, "high": 103, "low": 83, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "TARGET->AGONIST", "references": [ "b502f3f9-4b7c-48ff-b6cc-79d6bce4b0de" ], "related_substance": { "uuid": "96f1a035-7c18-4cdb-8117-7bd6d4e9af3f", "refuuid": "6a0dd737-07e2-43d3-aeca-be512e54b50a", "name": "5-HYDROXYTRYPTAMINE RECEPTOR 1E", "unii": "81L44VUK9K", "linking_id": "81L44VUK9K", "ref_pname": "5-HYDROXYTRYPTAMINE RECEPTOR 1E", "substance_class": "reference" } }, { "uuid": "ebb6541d-a495-4916-a084-8861cada5e97", "amount": { "uuid": "30925574-b20a-4ef5-a750-275324f8deae", "average": 30, "high": 40, "low": 20, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "TARGET->AGONIST", "references": [ "b502f3f9-4b7c-48ff-b6cc-79d6bce4b0de" ], "related_substance": { "uuid": "e01b5be2-4c10-4788-bd13-354ed114d27f", "refuuid": "16a75fdf-b595-4436-b1de-1d9e821d264a", "name": "5-HYDROXYTRYPTAMINE RECEPTOR 2B", "unii": "6E2Z4UWILI", "linking_id": "6E2Z4UWILI", "ref_pname": "5-HYDROXYTRYPTAMINE RECEPTOR 2B", "substance_class": "reference" } }, { "uuid": "a047f5b1-d869-4191-9648-26acff0cf264", "amount": { "uuid": "7fa74995-0e18-43e5-8a00-f8d6472ed7d4", "average": 27, "high": 33, "low": 21, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "OFF TARGET->LIGAND", "interaction_type": "BINDING", "references": [ "b502f3f9-4b7c-48ff-b6cc-79d6bce4b0de" ], "related_substance": { "uuid": "1e33c6fa-e8dc-4fd3-9319-2af663c2be3f", "refuuid": "a98f13f0-dc55-4a68-ad39-74c161d27375", "name": "D(3) DOPAMINE RECEPTOR", "unii": "G9XQ9S7T2F", "linking_id": "G9XQ9S7T2F", "ref_pname": "D(3) DOPAMINE RECEPTOR", "substance_class": "reference" } }, { "uuid": "95402d3a-8296-4197-ada2-918a1fd7de6c", "amount": { "uuid": "1948421d-1ab0-490c-be22-5c56d5470b1d", "average": 120, "high": 157, "low": 83, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "OFF TARGET->LIGAND", "interaction_type": "BINDING", "references": [ "b502f3f9-4b7c-48ff-b6cc-79d6bce4b0de" ], "related_substance": { "uuid": "0b6e59d5-e010-4a18-8c97-cae8da4e5f0b", "refuuid": "8a5e8a47-f550-4902-8d11-e0aa6920db0b", "name": "D(2) DOPAMINE RECEPTOR", "unii": "19GBD6T9L7", "linking_id": "19GBD6T9L7", "ref_pname": "D(2) DOPAMINE RECEPTOR", "substance_class": "reference" } }, { "uuid": "35039972-6f58-4d9d-92b3-39b1e1d3d605", "amount": { "uuid": "8af5f132-a1f8-4948-afdf-5073af6f83f9", "average": 180, "high": 213, "low": 147, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "OFF TARGET->LIGAND", "interaction_type": "BINDING", "references": [ "b502f3f9-4b7c-48ff-b6cc-79d6bce4b0de" ], "related_substance": { "uuid": "a693fd70-5249-4562-bf19-c0d4dfadab07", "refuuid": "84edf12e-87a3-43e0-8526-ad45513dcd09", "name": "D(1A) DOPAMINE RECEPTOR", "unii": "54202V7DRJ", "linking_id": "54202V7DRJ", "ref_pname": "D(1A) DOPAMINE RECEPTOR", "substance_class": "reference" } }, { "uuid": "671b29e7-4d28-4f0a-8f64-8345bf0b0c9b", "amount": { "uuid": "2f455ffe-90ef-4df2-96ed-120e2a90d7bc" }, "type": "PRECURSOR->PARENT", "references": [ "e8cf4538-b2f8-44e0-b7c2-6dc9f635efb4" ], "related_substance": { "uuid": "229bd0b3-b6a4-433e-bbda-72f75daf766b", "refuuid": "44bc8714-600a-401b-ab02-d9d0e54938bb", "name": "ERGOCRISTINE", "unii": "3E58HO2T0U", "linking_id": "3E58HO2T0U", "ref_pname": "ERGOCRISTINE", "substance_class": "reference" } } ], "substance_class": "chemical", "names": [ { "uuid": "150874b2-3d9d-4b84-829a-6f7a853c3ec3", "name": "(+)-LYSERGIC ACID DIETHYLAMIDE", "stdName": "(+)-LYSERGIC ACID DIETHYLAMIDE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "cdad751e-295f-427b-b801-f3145c766c3b" ], "display_name": false }, { "uuid": "f3a6438e-57a9-4572-8887-e9eb9b589653", "name": "(+)-LYSERGIDE (INCB:GREEN LIST)", "stdName": "(+)-LYSERGIDE (INCB:GREEN LIST)", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "0a4bc08a-5b0a-4ec2-ab26-cb716f74ffbf" ], "display_name": false }, { "uuid": "ca94a8eb-ec15-4780-965c-6fd272a54a9c", "name": "(6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide", "stdName": "(6AR,9R)-N,N-DIETHYL-7-METHYL-4,6,6A,7,8,9-HEXAHYDROINDOLO(4,3-FG)QUINOLINE-9-CARBOXAMIDE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "21d9c029-4091-450a-a3ef-9131e72dc6b3" ], "display_name": false }, { "uuid": "5afec5f8-c1c1-4557-a125-110405e01519", "name": "(8.BETA.)-9,10-DIDEHYDRO-N,N-DIETHYL-6-METHYLERGOLINE-8-CARBOXAMIDE", "stdName": "(8.BETA.)-9,10-DIDEHYDRO-N,N-DIETHYL-6-METHYLERGOLINE-8-CARBOXAMIDE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "a5965fbf-9cbd-4eef-b722-7d234dd7f8a8" ], "display_name": false }, { "uuid": "17db5e76-8661-4783-a98d-594bfc733bd2", "name": "9,10-DIDEHYDRO-N,N-DIETHYL-6-METHYL-ERGOLINE-8B-CARBOXAMIDE", "stdName": "9,10-DIDEHYDRO-N,N-DIETHYL-6-METHYL-ERGOLINE-8B-CARBOXAMIDE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "f5a10ff3-f712-4c67-ab5e-7746da6bf1ec" ], "display_name": false }, { "uuid": "ffbfdf93-5087-4643-81d1-9835c4c2dfc1", "name": "D-LSD", "stdName": "D-LSD", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "cdad751e-295f-427b-b801-f3145c766c3b" ], "display_name": false }, { "uuid": "3c8c31b1-fe14-4aad-94cd-6416a1639851", "name": "DEXTROLYSERGIC ACID DIETHYLAMIDE", "stdName": "DEXTROLYSERGIC ACID DIETHYLAMIDE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "cdad751e-295f-427b-b801-f3145c766c3b" ], "display_name": false }, { "uuid": "5bbd8b30-dea2-4b69-ab88-2772c2a9f953", "name": "ERGOLINE-8-CARBOXAMIDE, 9,10-DIDEHYDRO-N,N-DIETHYL-6-METHYL-, (5.BETA., 8.BETA.)-", "stdName": "ERGOLINE-8-CARBOXAMIDE, 9,10-DIDEHYDRO-N,N-DIETHYL-6-METHYL-, (5.BETA., 8.BETA.)-", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "736ca873-d4cd-4e78-abaa-7417889ae4a0" ], "display_name": false }, { "uuid": "cf94fae7-4819-4c82-b398-f5402ff65f9a", "name": "LSD", "stdName": "LSD", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "06674bab-b2d8-48e0-ad58-6989f958262b" ], "display_name": false }, { "uuid": "36725e5a-734c-47fb-b17a-3c5a98f9d2bb", "name": "LSD-25", "stdName": "LSD-25", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "0a4bc08a-5b0a-4ec2-ab26-cb716f74ffbf" ], "display_name": false }, { "uuid": "b5f601e2-0903-48f4-a43c-a9e99d550104", "name": "LYSERGIC ACID DIETHYLAMIDE", "stdName": "LYSERGIC ACID DIETHYLAMIDE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "06674bab-b2d8-48e0-ad58-6989f958262b" ], "display_name": false }, { "uuid": "fed4f20e-76a9-4c9e-b7b5-023130079b07", "name": "LYSERGIDE", "stdName": "LYSERGIDE", "type": "of", "languages": [ "en" ], "preferred": false, "references": [ "9788e089-d968-4b14-a9eb-cd08c135cb03", "c0e3932a-c59b-43f8-8384-4112402229ee", "b4eea337-fd19-47b5-b714-73bd9758b96f", "929c11f4-74ab-4008-92a6-b21008322de4", "9f9abd69-b7b4-45b9-8806-8cfdab2bff8e", "1e0bc673-063d-4807-a912-e797d78b1771", "950930e4-b10c-4e5f-90b2-981faefdd48b", "c35fa318-71a9-458f-8b73-0de5e7bd86d4", "82d8c6a9-d08c-4f36-8225-f0e580e39203" ], "display_name": true, "domains": [ "drug" ], "name_orgs": [ { "uuid": "82abc314-919e-4344-a544-f0e512d6307c", "name_org": "INN" } ] }, { "uuid": "8dd54b76-c6ea-4f8c-997f-567d3ad2826f", "name": "LYSERGIDE [HSDB]", "stdName": "LYSERGIDE [HSDB]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "950930e4-b10c-4e5f-90b2-981faefdd48b" ], "display_name": false }, { "uuid": "759c09f6-a6ef-47cd-86ee-86879e32f959", "name": "LYSERGIDE [MI]", "stdName": "LYSERGIDE [MI]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "b4eea337-fd19-47b5-b714-73bd9758b96f" ], "display_name": false }, { "uuid": "c62a902b-5515-a507-3461-c82713cf343b", "name": "Lysergide [WHO-DD]", "stdName": "LYSERGIDE [WHO-DD]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "2c97481d-36cf-4bf7-8f3b-b757c6585a47" ], "display_name": false }, { "uuid": "635691dc-6c91-43f2-8b26-5a63df9d825e", "name": "N,N-DIETHYLLYSERGAMIDE", "stdName": "N,N-DIETHYLLYSERGAMIDE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "f5a10ff3-f712-4c67-ab5e-7746da6bf1ec" ], "display_name": false }, { "uuid": "71833628-c84f-4f7b-ab58-c0364ee82a8d", "name": "lysergide [INN]", "stdName": "LYSERGIDE [INN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "9f9abd69-b7b4-45b9-8806-8cfdab2bff8e" ], "display_name": false } ], "references": [ { "uuid": "c0e3932a-c59b-43f8-8384-4112402229ee", "citation": "USP Dictionary 2008", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "f5a10ff3-f712-4c67-ab5e-7746da6bf1ec", "citation": "USP DICTIONARY", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "06674bab-b2d8-48e0-ad58-6989f958262b", "citation": "USP DICTIONARY 2008", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "736ca873-d4cd-4e78-abaa-7417889ae4a0", "citation": "STN", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "9f9abd69-b7b4-45b9-8806-8cfdab2bff8e", "citation": "INN Proposed List 8", "url": "https://www.who.int/medicines/publications/druginformation/innlists/PL08.pdf", "doc_type": "INN_LIST", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "b4eea337-fd19-47b5-b714-73bd9758b96f", "citation": "MERCK INDEX", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "950930e4-b10c-4e5f-90b2-981faefdd48b", "citation": "HSDB", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "0a4bc08a-5b0a-4ec2-ab26-cb716f74ffbf", "citation": "INCB", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "9788e089-d968-4b14-a9eb-cd08c135cb03", "citation": "WHO-DD", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "c492a6d1-ba29-4396-b649-5b621af01d8c", "citation": "USP-RS", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "a5965fbf-9cbd-4eef-b722-7d234dd7f8a8", "citation": "SCIFINDER", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "4b016d08-0889-474f-ad8e-51877b284c64", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493389708000, "tags": [ "NOMEN" ] }, { "uuid": "f0f9494b-4840-432b-9a31-a1c85cb9dd01", "citation": "JOURNAL OF CHROMATOGRAPHY B: BIOMEDICAL SCIENCES AND APPLICATIONS, VOLUME 724, ISSUE 1, 5 MARCH 1999, PAGES 23?33", "url": "http://www.sciencedirect.com/science/article/pii/S037843479800574X", "doc_type": "JOURNAL ARTICLE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "5d8bf034-7687-4c2c-8f50-614ad9f40ada", "citation": "SRS import [8NA5SWF92O]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=8NA5SWF92O", "doc_type": "SRS", "public_domain": true, "document_date": 1493389708000, "tags": [ "NOMEN" ] }, { "uuid": "82d8c6a9-d08c-4f36-8225-f0e580e39203", "citation": "LYSERGIDE [INN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "c35fa318-71a9-458f-8b73-0de5e7bd86d4", "citation": "LYSERGIDE [MI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "929c11f4-74ab-4008-92a6-b21008322de4", "citation": "LYSERGIDE [HSDB]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "1e0bc673-063d-4807-a912-e797d78b1771", "citation": "LYSERGIDE [WHO-DD]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "a76ca890-f997-4353-a038-a0a53f1b3a46", "citation": "LYSERGIC ACID DIETHYLAMIDE TARTRATE CI [USP-RS]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "bc4ae17d-5304-c667-760f-b86786883734", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+50-37-3", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "ec19f587-04cd-0e11-999c-fab3e689ba5a", "citation": "WEBSITE", "url": "https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=50-37-3", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "c9d1579d-a880-cca1-f5f3-6fa78e9c0ee6", "citation": "EU-SRS", "doc_type": "EMA LIST", "public_domain": true }, { "uuid": "ea13361d-d8b8-7f8f-7d3b-197998ac85b6", "doc_type": "SYSTEM", "public_domain": true }, { "uuid": "de5941ca-20b4-4192-a232-12882cc65582", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "681e3993-f6e8-4834-8ef1-bd6e12a4960e", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "4458083d-932f-4df8-a437-f817be5d1ef3", "citation": "Klette, Kevin L., et al. \"Metabolism of lysergic acid diethylamide (LSD) to 2-oxo-3-hydroxy LSD (OH-LSD) in human liver microsomes and cryopreserved human hepatocytes.\" Journal of analytical toxicology 24.7 (2000): 550-556.", "url": "https://academic.oup.com/jat/article/24/7/550/766958", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "92b30819-12d9-4ad2-884f-dc939b389926", "citation": "Klette, Kevin L., et al. \"Metabolism of lysergic acid diethylamide (LSD) to 2-oxo-3-hydroxy LSD (OH-LSD) in human liver microsomes and cryopreserved human hepatocytes.\" Journal of analytical toxicology 24.7 (2000): 550-556.", "url": "https://academic.oup.com/jat/article/24/7/550/766958", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "21d9c029-4091-450a-a3ef-9131e72dc6b3", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "b45491c0-bdbb-4424-b7ff-237e9904d014", "citation": "Acta Clin Belg Suppl 1999;1:94-6", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "cdad751e-295f-427b-b801-f3145c766c3b", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "c6826751-2276-4204-a386-a78b2a1055c5", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "28b0f01c-0ac0-47de-9969-43dc6bcac1db", "citation": "Halberstadt, Adam L., et al. \"Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).\" Neuropharmacology 172 (2020): 107856.", "url": "https://www.sciencedirect.com/science/article/pii/S0028390819304228?via%3Dihub", "doc_type": "JA", "public_domain": true }, { "uuid": "7bf14301-5db2-49ac-aac2-57bad9ed5093", "citation": "Halberstadt, Adam L., et al. \"Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).\" Neuropharmacology 172 (2020): 107856.", "url": "https://www.sciencedirect.com/science/article/pii/S0028390819304228?via%3Dihub", "doc_type": "JA", "public_domain": true }, { "uuid": "886c1d71-9665-44a9-82d8-71dc1dab2c48", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "5f567722-67d3-447c-ab84-b44b2d47853e", "citation": "Halberstadt, Adam L., et al. \"Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).\" Neuropharmacology 172 (2020): 107856.", "url": "https://www.sciencedirect.com/science/article/pii/S0028390819304228?via%3Dihub", "doc_type": "JA", "public_domain": true }, { "uuid": "39860e9a-54df-47ef-8295-f3cc15b82d01", "citation": "Halberstadt, Adam L., et al. \"Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).\" Neuropharmacology 172 (2020): 107856.", "url": "https://www.sciencedirect.com/science/article/pii/S0028390819304228?via%3Dihub", "doc_type": "JA", "public_domain": true }, { "uuid": "2c97481d-36cf-4bf7-8f3b-b757c6585a47", "citation": "WHO-DD", "doc_type": "WHO DRUG DICTIONARY", "public_domain": true }, { "uuid": "549fde70-9d06-468e-8a04-5b9afa511ca5", "citation": "https://www.deadiversion.usdoj.gov/schedules/orangebook/j_chemlist_regulated.pdf", "url": "https://www.deadiversion.usdoj.gov/schedules/orangebook/j_chemlist_regulated.pdf", "doc_type": "WEB PAGE", "public_domain": true }, { "uuid": "e8cf4538-b2f8-44e0-b7c2-6dc9f635efb4", "citation": "https://www.deadiversion.usdoj.gov/schedules/orangebook/j_chemlist_regulated.pdf", "url": "https://www.deadiversion.usdoj.gov/schedules/orangebook/j_chemlist_regulated.pdf", "doc_type": "WEB PAGE", "public_domain": true }, { "uuid": "b502f3f9-4b7c-48ff-b6cc-79d6bce4b0de", "citation": "Nichols, David E., et al. \"Lysergamides of isomeric 2, 4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N, N-diethyllysergamide (LSD).\" Journal of Medicinal Chemistry 45.19 (2002): 4344-4349.", "url": "https://pubs.acs.org/doi/pdf/10.1021/jm020153s", "doc_type": "JA", "public_domain": true } ], "definition_type": "PRIMARY", "moieties": [ { "uuid": "5fded8b2-4177-45fd-a129-9cff0fa19f79", "id": "5fded8b2-4177-45fd-a129-9cff0fa19f79", "molfile": "\n Marvin 01132104582D \n\n 24 27 0 0 1 0 999 V2000\n 4.5589 -3.0815 0.0000 C 0 0 1 0 0 0 0 0 0 1 0 0\n 5.2871 -3.4693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.2950 -4.3162 0.0000 N 0 0 1 0 0 0 0 0 0 0 0 0\n 6.0601 -4.7040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.5958 -4.7515 0.0000 C 0 0 2 0 0 0 0 0 0 1 0 0\n 4.5958 -5.6116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.9020 -6.0337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.9020 -6.9202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.4773 -6.9202 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 2.4773 -6.0337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.7413 -5.6353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.7307 -4.7911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.4457 -4.3848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.1712 -4.7726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.8677 -4.3637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.8677 -3.5327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.1712 -5.6116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.5483 -2.3428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.8123 -1.8283 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 5.1684 -1.9418 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 5.1763 -1.2928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.8701 -0.9366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.7699 -2.3771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 6.4822 -2.0447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1 2 1 0 0 0 0\n 1 16 1 0 0 0 0\n 1 18 1 1 0 0 0\n 2 3 1 0 0 0 0\n 4 3 1 0 0 0 0\n 5 3 1 6 0 0 0\n 5 6 1 0 0 0 0\n 5 15 1 0 0 0 0\n 7 6 1 0 0 0 0\n 8 7 2 0 0 0 0\n 7 17 1 0 0 0 0\n 8 9 1 0 0 0 0\n 9 10 1 0 0 0 0\n 10 11 1 0 0 0 0\n 10 17 2 0 0 0 0\n 11 12 2 0 0 0 0\n 12 13 1 0 0 0 0\n 13 14 2 0 0 0 0\n 14 15 1 0 0 0 0\n 17 14 1 0 0 0 0\n 16 15 2 0 0 0 0\n 19 18 2 0 0 0 0\n 20 18 1 0 0 0 0\n 21 20 1 0 0 0 0\n 23 20 1 0 0 0 0\n 22 21 1 0 0 0 0\n 24 23 1 0 0 0 0\nM END", "smiles": "CCN(CC)C(=O)[C@@H]1C=C2c3cccc4c3c(C[C@H]2N(C)C1)c[nH]4", "formula": "C20H25N3O", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ABSOLUTE", "count_amount": { "type": "MOL RATIO", "average": 1, "units": "MOL RATIO", "uuid": "65fdd0ba-489d-41b3-a070-aaa1885199cf" }, "defined_stereo": 2, "ez_centers": 0, "molecular_weight": "323.4328", "optical_activity": "UNSPECIFIED", "stereo_centers": 2 } ], "definition_level": "COMPLETE", "uuid": "47838978-2214-4228-a38b-9ed5b1b283a3", "version": "40", "structure": { "id": "6d6abcba-1173-4dff-9aca-43d7f5b1db3b", "molfile": "\n Marvin 01132105412D \n\n 25 28 0 0 1 0 999 V2000\n 3.8677 -4.3637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.5589 -3.0815 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0\n 3.8677 -3.5327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.9020 -6.0337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.5958 -4.7515 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0\n 3.1712 -4.7726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.2950 -4.3162 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 3.1712 -5.6116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.5483 -2.3428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.5958 -5.6116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 3.9020 -6.9202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.4773 -6.9202 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 5.2871 -3.4693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.4773 -6.0337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.1684 -1.9418 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 3.8123 -1.8283 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2.4457 -4.3848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 6.0601 -4.7040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.7307 -4.7911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.7413 -5.6353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.1763 -1.2928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.7699 -2.3771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.8701 -0.9366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 6.4822 -2.0447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.3082 -5.1050 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0\n 2 3 1 0 0 0 0\n 3 1 2 0 0 0 0\n 4 8 1 0 0 0 0\n 5 1 1 0 0 0 0\n 6 1 1 0 0 0 0\n 7 5 1 0 0 0 0\n 8 6 1 0 0 0 0\n 2 9 1 1 0 0 0\n 10 5 1 0 0 0 0\n 11 4 2 0 0 0 0\n 12 14 1 0 0 0 0\n 13 7 1 0 0 0 0\n 14 8 2 0 0 0 0\n 15 9 1 0 0 0 0\n 16 9 2 0 0 0 0\n 17 6 2 0 0 0 0\n 18 7 1 0 0 0 0\n 19 17 1 0 0 0 0\n 20 19 2 0 0 0 0\n 21 15 1 0 0 0 0\n 22 15 1 0 0 0 0\n 23 21 1 0 0 0 0\n 24 22 1 0 0 0 0\n 5 25 1 1 0 0 0\n 4 10 1 0 0 0 0\n 2 13 1 0 0 0 0\n 14 20 1 0 0 0 0\n 11 12 1 0 0 0 0\nM END", "smiles": "CCN(CC)C(=O)[C@@H]1C=C2c3cccc4c3c(C[C@@]2([H])N(C)C1)c[nH]4", "formula": "C20H25N3O", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ABSOLUTE", "defined_stereo": 2, "ez_centers": 0, "molecular_weight": "323.4328", "optical_activity": "( + )", "references": [ "5d8bf034-7687-4c2c-8f50-614ad9f40ada", "c0e3932a-c59b-43f8-8384-4112402229ee", "9f9abd69-b7b4-45b9-8806-8cfdab2bff8e" ], "stereo_centers": 2 }, "unii": "8NA5SWF92O" } ] }